logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
S

Statistics in Biopharmaceutical Research

IF1.3
Papers59
Citations
Journal Papers 59
Publication Date
delete
OFGSD: Optimal Futility Stopping Rules for Group Sequential Design
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteTeng, Zhaoyang; Zhao, Qiang; Tang, Rui; Liu, Yi
deleteShare
deleteSave
Statisticians at the Forefront of Health Technology Assessment: Aligning Regulatory and HTA Evidence Through Transdisciplinary Collaboration
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteJen, Min-Hua; Cai, Zhihong; Chu, Haitao; Becker, Ursula; Cappelleri, Joseph C.; Chen, Liang; Dohring, Orlando; Li, Yinglei; Mt-Isa, Shahrul; Ren, Min; Bridges, Ian
deleteShare
deleteSave
A Two-Stage Dose Optimization Framework for Oncology Drug Development with Multiple Efficacy and Safety Endpoints via an Integrated Benefit-Risk Assessment
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteChakraborty, Shubhadeep; Dubey, Abhishek K.; Kumar, Arun; Chan, Ivan
deleteShare
deleteSave
Challenges of Modeling Biomarker Effects on Time-to-Event Outcomes
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteWang, Tuo; Qu, Yongming
deleteShare
deleteSave
Statistical Methods for Quantitative Decision-Making in Vaccines Development
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteOvbude, Leroy Jide; Conti, Valentino; Solmi, Francesca; Ganyani, Tapiwa; Collignon, Olivier; Karkada, Naveen; Cheuvart, Brigitte; Callegaro, Andrea; Tibaldi, Fabian
deleteShare
deleteSave
Comparison of Methods to Analyze Time-to-Event Endpoints When Treatment Effect is Delayed
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteBehnisch, Rouven; Kirchner, Marietta; Kieser, Meinhard
deleteShare
deleteSave
Commentary on "Statistical Methodology Groups in the Pharmaceutical Industry"
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-21
delete0
PREAI
deleteWang, Li; Yu, Binbing; Mo, May; Roychoudhury, Satrajit; Yu, Ron; Wang, Chenguang; Takeda, Kentaro
deleteShare
deleteSave
Commentary on the Manuscript "Statistical Methodology Groups in the Pharmaceutical Industry," by Davenport et al
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-19
delete0
PREAI
deletePinheiro (retired), Jose
deleteShare
deleteSave
Bayesian and Frequentist Stratified Analysis of Treatment Effects with Survival Data in Comparative Trials
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-01
delete0
PREAI
deletePaydarfar, Daniel; Tian, Lu; Claggett, Brian L.; Tang, Rui (Sammi); Seibert, Tyler M.; Wei, Lee-Jen
deleteShare
deleteSave
An Enhanced Doubly Robust Causal Estimator for Nonrandomized Trials With Binary Outcome
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-01
delete0
PREAI
deleteZhou, Qiaohui; Yuan, Ao; Wang, Chenguang; Liu, Jing-ou; Tan, Ming T.
deleteShare
deleteSave
Prognostic Covariate Adjustment in Non-Ideal Conditions: Limitations and Doubly Robust Alternatives
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-01
delete0
PREAI
deleteJin, Man
deleteShare
deleteSave
Prevalence Estimation in Finite Populations Adjusted for Misclassification
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-01
delete0
PREAI
deleteMirzahosseini, Arash; Reiczigel, Jeno
deleteShare
deleteSave
6 Choose 4: A Framework to Understand and Facilitate Discussion of Strategies for Overall Survival Safety Monitoring
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete1
PREAI
deleteYung, Godwin; Rufibach, Kaspar; Wolbers, Marcel; Yan, Mark; Wang, Jue
deleteShare
deleteSave
Information Borrowing in Bayesian Clinical Trials: choice of Tuning Parameters for the Robust Mixture Prior
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWeru, Vivienn; Kopp-Schneider, Annette; Wiesenfarth, Manuel; Weber, Sebastian; Calderazzo, Silvia
deleteShare
deleteSave
Estimating Treatment Efficacy Controlling for Subsequent Therapy Usage: Comparison of Multiple Methods and Application to Hematologic Oncology Trials
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteZheng, Cheng; Mishra-Kalyani, Pallavi; Norsworthy, Kelly J.; Sridhara, Rajeshwari; Logan, Brent R.
deleteShare
deleteSave
Statistical Efficiency of Model-Robust Direct Regression Adjustment in Randomized Clinical Trials with Binary Outcomes
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHagiwara, Yasuhiro; Matsuyama, Yutaka
deleteShare
deleteSave
A Meta-Analysis Based Hierarchical Variance Model for Powering One and Two-Sample t-Tests
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteBarth, Jackson; Li, Ren-Cang; Wang, Xinlei
deleteShare
deleteSave
Bayesian Estimation of Dynamic Treatment Regimens in a Partially Randomized Patient Preference, Sequential, Multiple-Assignment, Randomized Trial
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWank, Marianthie; Tamura, Roy N.; Braun, Thomas M.; Kidwell, Kelley M.
deleteShare
deleteSave
Multiplicity Control in Clinical Trials with Adaptive Selection Followed by Group-Sequential Testing
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHua, Kaiyuan; Wang, Xiaofei; Luo, Xiaodong
deleteShare
deleteSave
Inverse Probability of Treatment Weighting: A Simple and Effective Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShao, Yongwu; Zhang, Zhiwei; Ye, Zhishen
deleteShare
deleteSave